The Microbiota: A New Variable Impacting Cancer Treatment Outcomes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28446507.
- Also identified by DOI 10.1158/1078-0432.CCR-17-0864 and PMC identifier 5627769.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Preclinical evidence has established that the host commensal microbiota can contribute to therapeutic response in cancer models, a finding supported by early clinical data. This connection between the microbiome and clinical outcome in oncology is cause for new consideration in the administration of antibiotics and microbiota-modulating interventions to improve outcomes. <i>Clin Cancer Res; 23(13); 3229-31. ©2017 AACR</i><i>See related article by Galloway-Peña et al., p. 3263</i>.
Medical subject headings
- Anti-Bacterial Agents
- Microbiota
- Neoplasms